Supernus Pharmaceuticals Inc (SUPN) Becoming More Attractive for Investors
In a filing, Supernus Pharmaceuticals Inc revealed its Sr. VP of IP, CSO Bhatt Padmanabh P. unloaded Company’s shares for reported $0.51 million on Mar 21 ’24. In the deal valued at $35.31 per share,14,491 shares were sold. As a result of this transaction, Bhatt Padmanabh P. now holds 8,570 shares worth roughly $0.28 million. […]
A company insider recently sold 62,366 shares of Supernus Pharmaceuticals Inc [SUPN]. Should You Sale?
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Supernus Pharmaceuticals Inc shares valued at $2,104,289 were sold by Bhatt Padmanabh P. on Mar 13 ’24. At $33.74 per share, Bhatt Padmanabh P. sold 62,366 shares. The insider’s holdings dropped […]
Recent Insider Activity Could Benefit Supernus Pharmaceuticals Inc (SUPN)
Supernus Pharmaceuticals Inc’s filing revealed that its Sr. VP of IP, CSO Bhatt Padmanabh P. unloaded Company’s shares for reported $2.1 million on Mar 13 ’24. In the deal valued at $33.74 per share,62,366 shares were sold. As a result of this transaction, Bhatt Padmanabh P. now holds 8,570 shares worth roughly $0.28 million. Then, […]
Jefferies gives a Buy recommendation for Supernus Pharmaceuticals Inc (SUPN)
Supernus Pharmaceuticals Inc’s recent filing unveils that its Sr. VP of IP, CSO Bhatt Padmanabh P. unloaded Company’s shares for reported $0.15 million on Feb 26 ’24. In the deal valued at $30.21 per share,5,000 shares were sold. As a result of this transaction, Bhatt Padmanabh P. now holds 8,570 shares worth roughly $0.28 million. […]
Taking a Closer Look At Supernus Pharmaceuticals Inc (SUPN) Following Its Recent Trade
Supernus Pharmaceuticals Inc’s recently made public that its Sr. VP of IP, CSO Bhatt Padmanabh P. unloaded Company’s shares for reported $0.15 million on Feb 26. In the deal valued at $30.21 per share,5,000 shares were sold. As a result of this transaction, Bhatt Padmanabh P. now holds 8,570 shares worth roughly $0.26 million. Then, […]
SUPN’s latest rating updates from top analysts.
In a filing, Supernus Pharmaceuticals Inc revealed its Sr. V.P., Regulatory Affairs Martin Tami Tillotson unloaded Company’s shares for reported $0.22 million on Jan 10. In the deal valued at $27.91 per share,8,000 shares were sold. As a result of this transaction, Martin Tami Tillotson now holds 85,664 shares worth roughly $2.53 million. Then, NEWHALL […]